Tina Mazaheri

ORCID: 0000-0001-8655-2372
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Bariatric Surgery and Outcomes
  • COVID-19 Clinical Research Studies
  • Diet and metabolism studies
  • Pharmacology and Obesity Treatment
  • Urological Disorders and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • SARS-CoV-2 detection and testing
  • Alcohol Consumption and Health Effects
  • Long-Term Effects of COVID-19
  • Ureteral procedures and complications
  • Alcoholism and Thiamine Deficiency
  • Extracellular vesicles in disease
  • Bone Metabolism and Diseases
  • Mesenchymal stem cell research
  • Pediatric Urology and Nephrology Studies
  • Cell Adhesion Molecules Research
  • Cardiac Valve Diseases and Treatments
  • Complementary and Alternative Medicine Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Renal and Vascular Pathologies
  • Pelvic and Acetabular Injuries
  • Vascular anomalies and interventions
  • Ocular Diseases and Behçet’s Syndrome

Imperial College London
2023-2025

Charing Cross Hospital
2025

Imperial College Healthcare NHS Trust
2024-2025

King's College Hospital NHS Foundation Trust
2020-2022

St Richard's Hospital
2020

Shaheed Rajaei Cardiovascular Medical and Research Center
2016

Iran University of Medical Sciences
2016

Tehran University of Medical Sciences
2011-2015

Zanjan University of Medical Sciences
2012-2014

Children's Medical Center
2010

Background Roux-en-Y gastric bypass is an established treatment option for type 2 diabetes and obesity. However, the optimal lengths small intestinal limbs remain controversial with variation in practice. A longer biliopancreatic limb length of 150 cm (‘Long Limb’) was hypothesised to better improve glycaemia compared standard a 50 (‘Standard Limb’). The aim trial evaluate short-term mechanistic outcomes long-term clinical safety Long Limb versus Standard bypass. Methods We undertook...

10.3310/mywg6289 article EN publisher-specific-oa Efficacy and Mechanism Evaluation 2025-01-01

Objectives Procalcitonin (PCT) is an acute-phase reactant with concentrations ≥0.5 μg/L indicative of possible bacterial infection in patients SARS-CoV-2 (COVID-19). Some severe COVID-19 develop cytokine storm secondary to virally driven hyper-inflammation. However, increased pro-inflammatory cytokines are also seen sepsis. This study aimed assess the clinical utility a panel assessment superinfections along PCT and C-reactive protein (CRP). Methods The retrospective analysis included serum...

10.1371/journal.pone.0266652 article EN cc-by PLoS ONE 2022-05-02

A chronic inflammation resulting from an imbalance between pro-inflammatory and anti-inflammatory cytokines in Hashimoto's thyroiditis (HT) might be responsible for IR hypothyroidism. This study was performed to investigate a probable association autoimmune background of hypothyroidism IR.In this clinical study, 63 subjects with 49 post-ablation were enrolled. All the participants euthyroid more than one year through Levothyroxine therapy. Serum concentrations Thyroid-stimulating Hormone...

10.1186/s40200-014-0103-4 article EN cc-by Journal of Diabetes & Metabolic Disorders 2014-10-29

Behçet's disease (BD) is a systemic vasculitis which characterised by oral, aphthous ulcers, genital skin lesions and ocular manifestations. Although the aetiopathogenesis of BD still unknown, critical role Th1 immune responses, neutrophil hyperactivation alongside overproduction pro-inflammatory cytokines such as interleukin-1 (IL-1), IL-6, IL-8, tumour necrosis factor-alpha (TNFα) particularly IL-17 have been demonstrated in immunopathogenesis disease. Despite significant progress...

10.1016/j.jmhi.2012.03.007 article EN cc-by-nc-nd Journal of Medical Hypotheses and Ideas 2012-01-01

Obesity affects one in four people the United Kingdom and costs National Health Service (NHS) ∼£6.5 billion annually. The glucagon-like peptide-1 (GLP-1) receptor analogues, such as once-daily subcutaneous Liraglutide 3.0 mg (Saxenda®) once-weekly Semaglutide 2.4 (Wegovy®), were approved by Institute of Care Excellence (NICE) a treatment for obesity funded NHS 2 years. Our local data shows that Saxenda is effective at reducing body weight glycaemia with diabetes; however, supply issues GLP-1...

10.1016/j.clinme.2024.100206 article EN cc-by-nc-nd Clinical Medicine 2024-04-21

Background: To reduce health inequalities, the creatinine-based chronic kidney disease epidemiology collaboration 2021 formula for estimated glomerular filtration rate (eGFR) is replacing 2009 formula, which required adjustment specifically Black individuals. We compared and formulae with cystatin C-based eGFR in people on antiretroviral therapy (ART) HIV RNA <200 c/ml. Methods: Cross-sectional analysis of paired serum creatinine C measurements. Bias, imprecision, accuracy, performance...

10.1097/qad.0000000000003466 article EN AIDS 2022-12-23

Public Health England has identified that in COVID-19, death rates among ethnic minorities far exceeds of the white population. While increase is likely to be multifactorial, date, no studies have looked see whether values for routine clinical biochemistry parameters differ between minority and individuals.

10.1136/jclinpath-2021-207446 article EN Journal of Clinical Pathology 2021-05-19
Coming Soon ...